Overview

Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence

Status:
Terminated
Trial end date:
2020-01-23
Target enrollment:
Participant gender:
Summary
The aim of this study is to study safety, tolerability and efficacy of muscle derived cell (MDC) therapy in children with bladder exstrophy epispadias induced urinary incontinence.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University